Andrej Spec, George R Thompson, Marisa H Miceli³, Justin Hayes, Laurie Proia, David McKinsey, Ana Belen Arauz, Kathleen Mullane, Jo-Ann Young, Gerald McGwin, Rachel McMullen, Tyler Plumley, Mary K Moore, Lee Ann McDowell, Carolynn Jones, Peter G Pappas, MSG-15: SUBA-Itraconazole versus Conventional Itraconazole in the Treatment of Endemic Mycoses – a multicenter, open-label, randomized comparative trial, Open Forum Infectious Diseases, 2024;, ofae010, https://doi.org/10.1093/ofid/ofae010

Little JS, Aleissa MM, Beluch K, Gonzalez-Bocco IH, Marty FM, Manne-Goehler J, Koo S, Hammond SP, Jacobson CA. Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma. Blood Adv. 2022 Aug 23;6(16):4821-4830. doi: 10.1182/bloodadvances.2022007474. PMID: 35802461; PMCID: PMC9631654.

Published Articles from the MSG 2006 – 2018

Pappas PG. Andes D, Schuster M, Hadley S, Rabkin J, Merion RM, Kauffman CA, Huckabee C, Cloud GA, Dismukes WE.  Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study.  Am J Transplant 2006;6:386-391.

Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH.  Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting.  Eur J Clin Microbiol Infect Dis. 2007;26(4):271-6.

Kauffman CA, Bustamante B, Chapman, SW, Pappas PG.  Guidelines for the management of sporotrichosis: 2007 Update by the Infectious Diseases Society of America.  Clin Infect Dis 2007;45:1255-65.  [IDSA MSG PRACTICE GUIDELINES- Sporotrichosis]

Chang DC, Burwell LA, Lyon GM, Pappas PG, Chiller TM, Wannemuehler KA, Fridkin SK, Park BJ.  Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis.  Infect Control Hosp Epidemiol 2008;29(1):25-30.

De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope W, Kibbler CC, Kullberg BJ, Marr KA, Perfect JR, Restrepo A, Ruhnke M, Segal JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE.  Revised definitions of the EORTC/MSG Consensus Group for invasive fungal diseases.   Clin Infect Dis 2008;46(12):1813-21. [MSG/EORTC FUNGAL DEFINITIONS, 2008]

Manosuthi W, Sungkanuparph S, Chottanapund S, Tansuphaswadikul S, Chimsuntorn S, Limpanadusadee P, Pappas PG.  Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitis.  Inter J STD AIDS 2008;19(4):268-71.

Chapman SW, Dismukes WE, Proia LA, Bradsher RW, Pappas PG, Threlkeld MG, Kauffman CA.  Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America.  Clin Infect Dis 2008;46(12):1801-12. [IDSA MSG PRACTICE GUIDELINES- Blastomycoses]

Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE.  Defining responses to therapy and study outcomes in clinical trials of invasive fungal infections: Mycoses Study Group (MSG) and European Organization for Research and Treatment of Cancer (EORTC) Consensus Criteria. Clin Infect Dis 2008;47(5):674-83. [MSG/EORTC FUNGAL DEFINITIONS, 2008]

Hadley S, Huckabee C, Pappas PG, Daly J, Rabkin J, Kauffman C, Merion R, Karchmer AW.  Outcomes of antifungal prophylaxis in high-risk liver transplant recipients. Transpl Infect Dis 2009;11:40-48. 

Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-35. [IDSA/MSG PRACTICE GUIDELINES- Candidiasis]

Manosuthi W, Sungkanuparph S, Anekthananon T, Supparatpinyo K, Nolen TL, Zimmer LO, Pappas PG, Larsen RA, Filler SG, Chetchotisakd P.  Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis.  Int J Antimicrob Agents 2009;34:494-6.

Pappas PG, Chetchotisakd P, Larsen RA, Manosuthi W, Morris MI, Anekthananon T, Sungkanuparph S, Supparatpinyo K, Nolen TL, Zimmer L, Kendrick AS, Johnson P, Sobel JD, Filler SG.  A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis.  Clin Infect is 2009;48(12):1775-83.

Ostrosky-Zeichner L, Pappas PG, Shoham S. Reboli A, Barron MA, Sims C, Wood C, Sobel JD.  Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit.  Mycoses 2010 epub ahead of print

Manosuthi W, Chetchotisakd P, Nolen TL, Wallace D, Sungkanuparph S, Anekthananon T, Supparatpinyo K, Pappas PG, Larsen RA, Filler SG, Andes D for the BAMSG 3-01 Study Team. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis infected patients. HIV Med 2010; 11: 276-81. [BAMSG # 3-01]

Sungkanuparph S, Filler SG, Chetchotisakd P, Pappas PG, Nolen TL, Manosuthi W, Anekthananon T, Morris MI, Supparatpinyo K, Kopetskie H, Kendrick AS, Johnson PC , Sobel JD, Larsen RA.  Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.  Clin Infect Dis 2009; 49:931-4.

Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito J, Balajee SA, Pappas PG, Moser SA.  Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).  J Clin Microbiol 2009;47:3271-5.  [TRANSNET]

Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, Andes D, Kontoyiannis DP, Perrone G, Peterson S, Brandt ME, Pappas PG, Chiller TM.  Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network (TRANSNET).  J Clin Microbiol 2009;47:3138-41. [TRANSNET]

Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble L, Herwaldt L, Ito J, Kontoyiannis DP, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson T, Perl TM, Oster RA, Schuster M, Walker R, Walsh TJ, Wannemuehler KA, Chiller TM.  Invasive fungal infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50:1101-11. [TRANSNET]

Perfect JR, Dismukes WE, Dromer F, Goldman D, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen M, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010; 50:291-322. [PRACTICE GUIDELINES- Cryptococcal disease]

Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Perl TM, Schuster MC, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG.  Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the TRANSNET database. Clin Infect Dis 2010; 50: 1091-1100. [TRANSNET]

Zimmer L, Nolen TL, Pramanpol S, Bradley ME, Pappas P, Chetchotisakd P.  International collaboration between US and Thailand on a clinical trial of treatment for HIV-associated cryptococcal meningitis.  Contemp Clin Trials 2010; 31:34-43.

Anekthananon T, Manosuthi W, Chetchotisakd P, Kiertiburanakul S, Supparatpinyo K, Ratanasuwan W, Pappas PG, Filler SG, Kopetskie H, Nolen TL, Kendrick AS, Larsen RA.  Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients. Int J STD AIDS 2011; 22: 665-670.

Baddley JW,Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA,   Oster RA, Anaissie EJ, Walsh TJ, Schuster MG, Wingard JR, Patterson TF, Ito JI, Williams OD, Chiller T, Pappas PG. Factors associated with mortality in transplant  patients with invasive aspergillosis. Clin Infect Dis 2010; 50: 1559-67.

Lockhart SR, Iqbal N, Wagner D, Pappas PG, Andes DR, Kauffman CA, Brumble LM, Hadley S, Walker R, Ito J, Baddley JW, Chiller T, Park BJ. A comparison of in vitro susceptibility of Candida species from cases of invasive candidiasis in solid organ and cell transplant recipients: TRANSNET 2001-2006. J Clin Micro 2011;49: 2404-10. [TRANSNET]

Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt L, Ito J, Kauffman CA, Lyon GM, Marr KA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wingard JR, Walsh TJ, Kontoyiannis DP. Invasive non-aspergillus mold  infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis 2011; 17:  1855-64.

Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, Schuster MG, Brizendine KD, Patterson TF, Lyon GM, Boekh M, Oster RA, Chiller T, Pappas  PG.  Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Med Mycol 2012:

Lockhart SR, Zimbeck AJ, Baddley JW, Marr KA, Andes KR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Pappas PG, Chiller T. In vitro susceptibility of Aspergillus to echinocandins: isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network. Antimicrob Agents Chemother 2011; 55: 3944-6. [TRANSNET]

Andes DR, Safdar N, Baddley JW, Playford G, Reboli A, Rex JH, Sobel JD, Pappas PG, Kullberg BJ for the Mycoses Study Group. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.  Clin Infect Dis 2012; 54:1110-22.

Pappas PG, Kontoyiannis DP, Perfect JR, Chiller TM. Real-time treatment guidelines: considerations during the Exserohilum rostratum outbreak in the United States. Antimicrob Agent Chemo 2013;57:1573-6.

Doligalski CT, Benedict K, Cleveland AA, Park B, Derado G, Pappas PG, Baddley JW, Zaas DW, Harris MT, Alexander BD. Invasive Mold Infections in Lung Transplant  Recipients:  Epidemiology and Risk Factor Analysis. Am J Transplant 2014; 14:1328-33.

Ostrosky-Zeichner L, Shoham S, Vazquez J, Reboli A, Betts R, Barron MA, Schuster M, Judson MA, Revankar SG, Caeiro JP, Mangino JE, Mushatt D, Bedimo R, Freifeld A, Nguyen MH, Kauffman CA, Dismukes WE, Westfall AO, Deerman JB, Wood C, Sobel JD, Pappas PG. MSG 01: A randomized, double-blind placebo controlled trial of caspofungin prophylaxis followed by pre-emptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis. 2014; 58:1219-26. [MSG #01]

Kauffman CA, Freifeld AG, Andes DR, Baddley JW, Herwaldt L, Walker R, Alexander BD, Anaissie EJ, Ito J, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Schuster M, Knapp K, Wannemuehler KA, Chiller TM, Pappas PG. Endemic fungal infections in hematopoietic cell solid organ and transplant recipients enrolled in the Transplant Associated Infection Surveillance Network (TRANSNET). Transplan Infect Dis 2014;16:213-24. [TRANSNET]

Boehme AK, McGwin G, Andes DR, Lyon, GM, Chiller T, Pappas PG, Baddley JW.  Race and Invasive Fungal Infection in Solid Organ Transplant Recipients. Ethnicity and  Dis 2014; 24:382-5.

Herbrecht R, Patterson TF, Slavin MA, Marchetti O, Maertens J, Johnson EM, Schlamm HT, Donnelly JP, Pappas PG. Application of the 2008 Definitions for Invasive Fungal Diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the EORTC Infectious Diseases Group. Clin Infect Dis 2015; 60:713-20 [MSG 05]

MarrKA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely OA, Heinz WJ,

Jagannatha S, Koh LP, Kontoyiannis DP, Lee DG, Nucci M, Pappas PG, Slavin MA,  Queiroz-Telles F, Selleslag D,Walsh TJ, Wingard JR, Maertens J.Combination  ntifungal Therapy for Invasive Aspergillosis: A Randomized Trial. Ann Intern Med. 2015 Jan; 162(2):81-9. PMID: 25599346

McCarty TP, Baddley JW,Wals TJ, AlexanderBD, Kontoyiannis DP, Perl TM, Walker R, Patterson TF, Schuster MG, LyonsGM, Wingard JR, Andes DR, Park BJ, Lockhart S, Pappas PG. Phaeohyphomycosis in Transplant Recipients: Results from the Transplant Associated Infection Surveillance Network. Med Mycol 2015 Jun; 53(5):440-6. PMID: 25908651 [TRANSNET, MSG 06]

McCotter OZ, Smith RM, Westercamp M, Kerkering TM, Malani AN, Latham R, Peglow S, Mody RK, Pappas PG, Chiller TM. Update on Multistate Outbreak of Fungal Infections Associated with Contaminated Methylprednisolone Injections, 2012–2014. MMWR. 2015 Oct; 64(42):1200-1. PMID: 26513534

PappasPG, KauffmanCA, AndesDR, Cornelius JC, MarrKA, Ostrosky-ZeichnerL,   ReboliAC, SchusterMG, VazquezJA, WalshTJ, ZaoutisTE, Sobel JD.  ExecutiveSummary: Clinical practice guidelines for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb; 62(4):409-17. PMID 26810419 [IDSA/MSG PRACTICE GUIDELINES- Candidiasis]

Andes DR, Safdar N, Baddley JW, Alexander B, Brumble L, Freifeld A, Hadley S, Herwaldt L, Kauffman C, Lyon GM, Morrison V, Patterson T, Perl T, Walker R, Hess T, Chiller T, Pappas PG. TRANSNET Investigators. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network(TRANSNET). Transpl Infect Dis. 2016 Sep 19.[Epub ahead of print] PMID:27643395  [TRANSNET]

Chiotos K, Vendetti N, Zaoutis T, Baddley J, Ostrosky-Zeichner L; Pappas PG, Fisher,B. Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12) J Antimicrob Chemo 2016; 71: 3536-9. PMID: 27494929 [MSG #12]

Schuster MG, Cleveland AA, Dubberke ER, Kauffman CA, Avery RK, Husain S, Paterson DL, Silveira FP, Chiller TM, Benedict K, Murphy K, Pappas PG. Infections in Hematopoietic Cell Transplant (HCT) Recipients: Results from The Organ Transplant Infection Project (OTIP), a Multi-Center, Prospective, Cohort Study. Open Forum Infect Dis 2017: ofx050. doi: 10.1093/ofid/ofx050. PMID: 28491889 [OTIP]

Revankar SG, Baddley JW, Chen S, KauffmanCA, SlavinM, VazquezJA, Seas C, Morris MI, Nguyen H, ShohamS, Thompson IIIGR, Alexander B, SimkinsJ, Ostrosky-Zeichner L, Mullane K, Alangaden G, Andes DR, Cornely O, Wahlers K, Lockhart S,  Pappas PG. A Mycoses Study Group international prospective study of phaeohyphomycosis: an analysis of 99 proven and probable cases. Open Forum Infect Dis 2017; 4: ofx200, doi:10.1093/ofid/ofx200 [ MSG #06 ]

Avery RK, Silveira FP, Benedict K, Cleveland AA, Kauffman CA, Schuster MG,  Dubberke ER, Husain S, Paterson D, Chiller T, Pappas PG. Cytomegalovirus Infections in Lung and Hematopoietic Cell Transplant Recipients in the Organ Transplant Infection Prevention and Detection (OTIP) Study: a Multi-Year, Multi-Center Prospective Cohort Study. Trans Infect Dis 2018 Jun;20(3):e12877. doi: 10.1111/tid.12877. Epub 2018 Mar    30. PMID:29512935  [OTIP]

Dubberke ER, Reske RA, Olsen MA, Bommarito K, Cleveland AA, Silveira FP, Schuster  MG, Kauffman CA, Avery RK, Pappas PG, Chiller TM. Epidemiology and Outcomes of   Clostridium difficile Infection in Allogeneic Hematopoietic Cell and Lung Transplant Recipients. Transpl Infect Dis. 2018 Apr;20(2):e12855. doi: 10.1111/tid.12855. Epub 2018 Mar 6. PMID:29427356  [OTIP]

Submitted Articles of the MSG

Spec A, Pullman J, Thompson GR, Powderly WG, Tobin EH, Vazquez J, Wring S, Angulo D, Helou S, Pappas PG, and the Investigators of the Mycoses Study Group.   MSG-10: A prospective, phase 2, multicenter, open-label, randomized, comparative study to estimate the safety, tolerability, and pharmacokinetics of oral enfumifungin vs fluconazole following initial echinocandin therapy for invasive candidiasis. Submitted Antimicrob Agent Chemo. [MSG #10]

Marr  KA, Sun Y, Spec A; Na Lu¹, Panackal A, Bennett J, ,Pappas P, Ostrander D, Datta K, Zhang SX, Williamson PR, On Behalf of the Cryptococcus Infection Network Cohort (CINCH) Study Working Group A Multicenter, Longitudinal Cohort Study of  Cryptococcosis in HIV-Negative People in the United States. Submitted Clin Infect Dis [MSG # 11 ]

Published Abstracts of the MSG: 2002 – 2017

Karchmer AW, Pappas PG, Merion R, Cloud G, Hadley S, Rabkin J, Schuster M, Andes D, Kauffman C, Delaney J, Daly J, Kusne S, Alexander B, and the MSG Study Group #44 NIAID Sponsored Mycoses Study Group.  Invasive infection in liver transplant recipients (LTR) considered at low risk.  40^th Annual IDSA Meeting, Abstract #16.  October 24-27, 2002, Chicago, IL.   [NIAID MSG 44]

Pappas PG, Morgan J, Hajjeh RA, and the Transplant Associated Infection Surveillance Network (TRANSNET). Prospective surveillance for invasive fungal infections (IFIs) in hematopoietic stem cell (HSCTs) and solid organ transplant recipients (SOTs) in the United States.  43^RD Annual ICAAC Conference, Abstract #M1010.  September 14-17, 2003, Chicago, Illinois.  [TRANSNET]

Baddley JW, Park B, Marr KA, Andes DR, Kontoyiannis DP, Hadley S, Schuster M, Alexander BD, Walsh TJ, Oster RA, Pappas PG, TRANSNET Investigators.  Factors influencing mortality in transplant recipients with invasive aspergillosis.  42^nd Annual IDSA Meeting, Abstract #673.  September 30-October 3, 2004, Boston, MA.  [TRANSNET]

Safdar N, Andes DR, Schuster N, Hadley S, Alexander B, Somani J, Brumble L, Kauffman C, Pappas PG, CDC TRANSNET.  Epidemiology and risk factors associated with Candida non-albicans infection in organ transplant recipients: prospective surveillance results from the TRANSNET database.  42^nd Annual IDSA Meeting, Abstract #682.  September 30-October 3, 2004, Boston, MA.  [TRANSNET]

Park BJ, Kontoyiannis DP, Pappas PG, Wannemuehler KA, Anaissie E, Fridkin SK, Walsh TJ, TRANSNET Investigators; CDC.  Comparison of zygomycosis and fusariosis to invasive aspergillosis (IA) among transplant recipients reporting to TRANSNET.  44^th Annual ICAAC Meeting, Abstract #M-666.  October 30-November 2, 2004,Washington, DC.  [TRANSNET]

Andes D, Safdar N, Hadley S, Alexander B, Schuster M, Somani J, Brumble L, Kauffman C, Morrison V, Pappas P; CDC TRANSNET, Atlanta, GA.  Epidemiology of invasive candida infections in solid organ and hematologic transplantation; prospective surveillance results from the TRANSNET database.  44^th Annual ICAAC Meeting, Abstract #M-1014.  October 30-November 2, 2004,Washington, DC.  [TRANSNET]

Morgan J, Alexander B, Wannemuehler K, Fan K, Daram P, Marr K, Kontoyiannis D, Kauffman C, Ito J, Hadley S, Fridkin SK, Pappas PG, Walsh T, TRANSNET Investigators.  Quantification of risk for invasive fungal infections (IFI) among transplant (TX) recipients reporting to TRANSNET.  44^th Annual ICAAC Meeting, Abstract #M-1058.  October 30-November 2, 2004,Washington, DC.  [TRANSNET]

Hadley S, Pappas P, Lyon M, Alexander B, Kauffman C, Andes D, Freifeld A, Fan K, Morgan J, TRANSNET Investigators.  Cryptococcus neoformans infections among solid organ transplant recipients reporting to TRANSNET.  43^rd Infectious Diseases Society of America Annual Meeting, Abstract #736.  October 6-9, 2005, San Francisco, CA. [TRANSNET]

Freifeld A, Kauffman C, Pappas PG, Walker R, Andes D, Hadley S, Fan K, Morgan J, and TRANSNET investigators.  Endemic fungal infections among solid organ transplant recipients.  43^rd Infectious Diseases Society of America Annual Meeting, Abstract #737.  October 6-9, 2005, San Francisco, CA [TRANSNET]

Andes D, Safdar N, Alexander B, Fridkin S, Hadley S, Kauffman C, Brumble L, Schuster M, Walker, Pappas P.  Comparative epidemiology of invasive Candida (IC) infections among organ transplant recipients (OTRs): prospective surveillance results from the CDC TRANSNET database.  43^rd Infectious Diseases Society of America Annual Meeting, Abstract #741.  October 6-9, 2005, San Francisco, CA. [TRANSNET]

Miller RA, Park BJ, Fridkin SK, Morrison VA, Pappas PG, Alexander B, Schuster M, Diekema DJ, TRANSNET Investigators.  Characterization of very late onset invasive aspergillosis.  43^rd Infectious Diseases Society of America Annual Meeting, Abstract #744.  October 6-9, 2005, San Francisco, CA. [TRANSNET]

Park BJ, Morrison VA, Kontoyiannis DP, Ito J, Walsh TJ, Pappas PG, Fridkin SK, Marr KA, TRANSNET Investigators.  Description of very-late invasive mound infections among hematopoietic stem cell transplant recipients reported in TRANSNET.  43^rd Infectious Diseases Society of America Annual Meeting, Abstract #745.  October 6-9, 2005, San Francisco, CA. [TRANSNET]

Morgan J, Friefeld A, Fridkin S, Kuehnert M, Pappas PG, Kauffman C, and the TRANSNET investigators.  Attempting to define organ transmitted histoplasmosis (OTH) utilizing data from TRANSNET National Surveillance Project.  Focus on Fungal Infections 2006. [TRANSNET]

Chang D, Burwell L, Lyon G, Abdulhafid G, Pappas P, Chiller T, Fridkin S, Park B.  Validation of the transplant associated infection surveillance network (TRANSNET) for detecting invasive aspergillosis among transplant recipients.  Focus on Fungal Infections 17, Abstract #P-0012.  March 7-9, 2007, San Diego, CA. [TRANSNET]

Park BJ, Pappas PG, Marr KA, Anaissie EJ, Ito J, Alexander BD, Walsh TJ, Kontoyiannis DP. Recent epidemiology of zygomycosis (GM) among organ transplant (OT) and stem cell transplant (SCT) recipients: results from the TRANSNET Surveillance Network.  47^th Annual ICAAC, Abstract #M-618.  September 17, 2007, Chicago, IL.   [TRANSNET]

Pappas PG, Nolen T, Chetchotisakd P, Larsen R, Manosuthi W, Filler S, BAMSG 3-01 Study Team.  Fluconazole (Flu) plus amphotericin B (AmB) vs. AmB alone for primary treatment of AIDS-associated cryptococcal meningitis (CM): results of a phase II trial.  47^th Annual ICAAC, Abstract #M-626.  September 17, 2007, Chicago, IL. [BAMSG #3-01]

Ostrosky-Zeichner L, Sobel J, Pappas P, Shoham S, Barron M, Reboli A, Kauffman C, Donowitz G, Clark N, Walsh T, Akins R, Mandviwala T, Shinde R, Bradley ME, Nolen T, Kendrick A, Wallace D.  Pilot study of risk-based caspofungin (CFG) prophylaxis in the ICU: lessons from a multicenter, randomized, double-blind trial and insights into diagnostic performance of surrogate markers.  47^th Annual ICAAC, Abstract #M-1158.  September 18, 2007, Chicago, IL. [MSG #04]

Pappas PG, Kauffman C, Alexander B, Andes D, Hadley S, Patterson T, Walker R, Morrison V, Perl T, Wannemuehler K, Chiller T.  Prospective surveillance of invasive fungal infections (IFIs) among organ transplant recipients (OTRs) in the US 2001-2006: review of TRANSNET. 47^th Annual ICAAC, Abstract #M-1195.  September 18, 2007, Chicago, IL. [TRANSNET]

Kontoyiannis DP, Marr K, Wannemuehler KA, Park BJ, Ito JI, Brown J, Anaissie EJ, Perl TM, Schuster M, Wingard J, Walsh TJ, Pappas PG.  Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the TRANSNET database.  47^th Annual ICAAC, Abstract #M-1196.  September 18, 2007, Chicago, IL. [TRANSNET]

Baddley JW, Kano R, Brandt ME, Marr KA, Kauffman CA, Andes DA, Moser SA, Pappas PG, Balajee SA.  Molecular characterization and antifungal susceptibilities of Aspergilli from the Transplant Associated Infection Surveillance Network (TRANSNET).  47^th Annual ICAAC, Abstract #M-2019.  September 20, 2007, Chicago, IL.  [TRANSNET]

Baddley JW, Andes DR, Anaissie EJ, Oster RA, Kauffman CA, Freifeld A, Perl TM, Ito JI, Pappas PG.  Factors associated with mortality in transplant recipients with candidemia: results from the Transplant Associated Infection Surveillance Network (TRANSNET).  45^th Annual Meeting of IDSA, Abstract #656.  October 6, 2007, San Diego, CA. [TRANSNET]

Baddley JW, Marr KA, Andes DR, Kontoyiannis DP, Patterson TF, Anaissie EJ, Walsh TJ, Alexander BD, Schuster M, Oster RA, Pappas PG.  Epidemiology of Aspergillus terreus infection in transplant recipients from Transplant Associated Infection Surveillance Network (TRANSNET).  45^th Annual Meeting of IDSA, Abstract #175.  October 5, 2007, San Diego, CA. [TRANSNET]

Kano R, Perrone G, Peterson S, Baddley JW, Marr KA, Alexander B, Andes D, Kontoyiannis D, Pappas PG, Balajee SA.  Comparative sequence analysis of multiple loci reveal rare Aspergillus species in transplant recipients (TRANSNET Study).    Advances against Aspergillosis 2007, Miami, FL  [TRANSNET]

Wagner DL, Hussain S, Paterson DL, Kauffman CA, Dubberke ER, Schuster MG, Pappas PG, Avery RK, Wannemuehler KA, Park BJ, Chiller TM.  Preliminary description of the Organ Transplant Infection Project (OTIP), a multi-year cohort study of infections in stem cell and lung transplant recipients. ICEID, 2008 Atlanta, GA [OTIP]

Park BJ, Kontoyiannis DP, Marr K, Wannemuehler K, Ito JI, Brown J, Anaissie EJ, Perl TM, Schuster M, Wingard JR, Walsh T, Chiller TM, Pappas PG.  Prospective surveillance for invasive fungal infections (IFIs) in hematopoietic stem cell transplant recipients (HSCTs), 2001-2006: overview of the TRANSNET database. ICEID,2008,  Atlanta, GA. [TRANSNET]  

Chiller TM, Kauffman C, Alexander B, Andes D, Hadley S, Patterson T, Walker R, Morrison V, rumble L, Freifeld A, Park BJ, Wannemuehler K, Pappas PG.  Prospective surveillance of invasive fungal infections (IFIs) among solid organ transplant (SOT) recipients in the US 2001-2006: review of TRANSNET. ICEID Conference, 2008 Atlanta, GA. [TRANSNET]

Baddley J, Marr K, Wingard J, Patterson T, Waterbor J, Kempf M, Williams O, Andes D, Kontoyiannis D, Pappas P, and TRANSNET Investigators.  Invasive aspergillosis in transplant patients: description of treatment practices and predictors of use of primary combination therapy. 3^rd Advances against Aspergillosis, Abstract #52. January 2008, Miami, FL. [TRANSNET]

Manosuthi W, Chetchotisakd P, Sungkanuparph S, Anekthananon T, Supparatpinyo K, Nolen TL, Wallace D, Pappas PG, Larsen RA, Filler SG, Andes D.  Serum and cerebrospinal fluid (CSF) concentration monitoring for high dose fluconazole (FLU) in HIV-associated cryptococcal meningitis (CM) infected patients. Conference on Retroviruses and Opportunistic Infections. (WHERE, WHEN?)

Wagner DL, Kauffman CA, Dubberke ER, Schuster MG, Pappas PG, Avery RK, Silveira F, Paterson KL, Wannemuehler KA, Park BJ, Chiller TM.  Preliminary mortality analysis of the Organ Transplant Infection Project (OTIP), a multiyear cohort study of infections in stem cell (SCT) and lung transplant (LT) recipients.  48th Annual ICAAC/IDSA 46^th Annual Meeting (Joint Meeting), Abstract #K-1473.  Washington, DC.  October 26, 2008. [OTIP]

Ostrosky-Zeichner L, Aranha L, Eggiman P, Garbino J, Herbrecht R, Leon C, Lortholary O, Pappas P, Sobel J, Sorrell T, Muller E.  Preliminary results of a multicenter, international, retrospective study to validate a clinical prediction rule (CPR) to identify critically ill patients at risk of invasive candidiasis (IC) for treatment with empirical antifungal therapy (TREAT Study).    48th Annual ICAAC/IDSA 46^th Annual Meeting (Joint Meeting), Abstract #M-1853.  Washington, DC.  October 27, 2008.

Manosuthi W, Sungkanuparph S, Anekthananon T, Supparatpinyo K, Nolen T, Pappas P, Larsen R, Filler S, Chetchotisakd P.  Effect of high dose fluconazole (FLU) on QT interval in HIV-associated cryptococcal meningitis (CM) infected patients.  48th Annual ICAAC/IDSA 46^th Annual Meeting (Joint Meeting), Abstract #M-2176.  Washington, DC.  October 27, 2008.

Knapp K, Prasad P, Zaoutis T, Chiller TM, Freifeld AG, Kauffman CA, Ito JI, Marr KA,  Perl TM, Papanicolaou G, Kontoyiannis DP, Pappas PG, Walsh T; Pediatric TRANSNET Study Group, Birmingham, AL.  Invasive fungal infections among pediatric transplant recipients from the Transplant-Associated Infection Surveillance Network (TRANSNET).  50th Annual ICAAC, Boston, MA.  Abstract #M-1054.  September 13, 2010.  [TRANSNET]

Luis Ostrosky-Zeichner, Shmuel Shoham, Jose Vazquez, Annette Reboli, Robert Betts, Michelle Barron, Mindy Schuster, Mark Judson, Sanjay Revankar, Juan Pablo Caeiro, Julie E. Mangino, David Mushatt, Roger Bedimo, Allison Freifeld, M. Hong Nguyen, Carol Kauffman, Robert A. Larsen, William E. Dismukes, Andy O. Westfall, Jeanna Beth Deerman, Craig Wood, Jack D. Sobel and Peter G. Pappas. MSG-01: A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of Caspofungin (CAS) Prophylaxis vs Placebo Followed by Pre-Emptive Therapy for Invasive Candidiasis (IC) in High-Risk Adults in the Critical Care Setting. Abstract presented as oral late-breaker at SHEA Conference in Dallas, Tx on April 3, 2011.

Herbrecht R, Patterson TF, Slavin MA, Marchetti O, Maertens J, Schlamm HT, Donnelly JP, Pappas PG. Application of the 2008 definitions for invasive fungal infections to the ‘voriconazole vs amphotericin B for therapy of invasive aspergillosis’ trial. A collaborative EORTC/MSG study (MSG 05). Abstract M-1225, 52^nd Annual ICAAC, San Francisco, CA, September 9-12, 2012. [MSG 05]

McCarty TP, Baddley J, Alexander BA, Kontoyiannis D, Marr KA, Park BJ, Perl TM, Schuster M, Walker R, Walsh TJ, Pappas PG. Phaeohyphomycosis and Scedosporiosis in Transplant Recipients: Results from the Transplant Associated Infection Surveillance Network. Infectious Diseases Society of America Annual Meeting, San Diego, CA, October 17-21, 2012.  [TRANSNET]

Kieren A. Marr KA, Schlamm H, Rottinghaus ST, Jagannatha S, Bow EJ, Wingard JR, Pappas P, Herbrecht R, Walsh TJ, Maertens J, and the Mycoses Study Group A randomised, double-blind study of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), London, UK, 31 March – 3 April 2012

Baddley JW, Perfect JR, Chen S, Sorrell TC, Galanis E, Debess E, Marsden-Haug N, Benedict K, Chideya-Chihota S, Huisingh C, Pappas PG. Epidemiology and outcomes of cryptococcosis: description of an international, multi-center cohort. Abstract M-1787c. ICAAC, Washington DC, September 6-9, 2014. [MSG #07]

Pappas PG. Fungal infections associated with injection of contaminated steroids: lessons from long-term follow up studies. Abstract K-532. ICAAC, Washington DC, September 6-9, 2014. [MSG #08 ]

Revanker SG, Baddley J, Chen S, Slavin M, Vazquez J, Seas C, Shoham S, Morris M, Kauffman C, Perfect J, Nguyen H, Thompson G, Wahlers K, Vehreschild M, Pappas P. Mycoses Study Group 06: a registry of 50 cases of phaeohyphomycosis. Abstract M- 1758. ICAAC, Washington DC, September 6-9, 2014. [MSG #06]

Westercamp M, Malani A, Cleveland AA, Kauffman C, Smith RM, Latham R, Peglow S, Kerkering T, Wright P, Triplett P, Ledtke C, Deerman JB, Chiller T, Pappas PG.  Treatment and outcomes among patients with fungal meningitis and epidural abscess due to contaminated epidural methylprednisolone acetate injections-United States 2012- 2013. Abstract M-1787b. ICAAC, Washington DC, September 6-9, 2014. [MSG #08]

Mody RK, Cleveland A, Avery R, Schuster M, Silveira F, Hussain S, Derado G, Chiller T, Pappas P. Incidence of Invasive Fungal Infections among Lung Transplant Recipients: a Multicenter Study. Abstract 1208. IDWeek 2015; San Diego CA, October 7-11, 2015.

Revankar S, Baddley J, Chen S, Vehreschild M, Wahlers K, Pappas P. MSG-06: A Registry of 90 Cases of Phaeohyphomycosis. Abstract 464. IDWeek 2015; San Diego CA, October 7-11, 2015. [MSG #06]

Vendetti N, Baddley J, Ostrosky-Zeichner L, Pappas PG, Theoklis Zaoutis T, Fisher BT. MSG12: Comparative effectiveness of echinocandins vs. fluconazole therapy for the treatment of adult candidemia due to Candida parapsilosis. Abstract 217. IDWeek 2015; San Diego CA, October 7-11, 2015. [MSG #12]

Pappas P, J. Pullman J, G. Thompson GR, Powderly W, Spec A, Tobin EH, Vazquez J, Wring S, Angulo D, Helou S, and the Investigators of the Mycoses Study Group. A  Prospective, Phase 2, Multicenter, Open-Label, Randomized, Comparative Study to Estimate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Oral SCY-078 vs.  Standard-of-Care Following Initial Intravenous Echinocandin Therapy in the Treatment of Invasive Candidiasis (including Candidemia) in Hospitalized Non-neutropenic Adults (Mycoses Study Group 010). ECCMID April 24-27, 2017, Vienna Austria. [MSG #10]